1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Sugar-Based Excipients Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Sugar-Based Excipients Market Revenue and Volume Forecast, by Product Type
8.1.1. Sugar Alcohols (Polyols)
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Actual Sugars
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Artificial Sweeteners
8.1.3.1. Market Revenue and Volume Forecast
9.1. Sugar-Based Excipients Market Revenue and Volume Forecast, by Form
9.1.1. Powders/Granule
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Direct Compression Sugars
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Syrups & Liquid Solutions
9.1.3.1. Market Revenue and Volume Forecast
10.1. Sugar-Based Excipients Market Revenue and Volume Forecast, by Application/Functionality
10.1.1. Fillers & Diluents
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Flavoring & Taste-Masking Agents
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Tonicity Agents
10.1.3.1. Market Revenue and Volume Forecast
11.1. Sugar-Based Excipients Market Revenue and Volume Forecast, by End-User
11.1.1. Pharmaceutical Companies
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. CDMOs (Contract Manufacturers)
11.1.2.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product Type
12.1.2. Market Revenue and Volume Forecast, by Form
12.1.3. Market Revenue and Volume Forecast, by Application/Functionality
12.1.4. Market Revenue and Volume Forecast, by End-User
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product Type
12.1.5.2. Market Revenue and Volume Forecast, by Form
12.1.5.3. Market Revenue and Volume Forecast, by Application/Functionality
12.1.5.4. Market Revenue and Volume Forecast, by End-User
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product Type
12.1.6.2. Market Revenue and Volume Forecast, by Form
12.1.6.3. Market Revenue and Volume Forecast, by Application/Functionality
12.1.6.4. Market Revenue and Volume Forecast, by End-User
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product Type
12.2.2. Market Revenue and Volume Forecast, by Form
12.2.3. Market Revenue and Volume Forecast, by Application/Functionality
12.2.4. Market Revenue and Volume Forecast, by End-User
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product Type
12.2.5.2. Market Revenue and Volume Forecast, by Form
12.2.5.3. Market Revenue and Volume Forecast, by Application/Functionality
12.2.5.4. Market Revenue and Volume Forecast, by End-User
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product Type
12.2.6.2. Market Revenue and Volume Forecast, by Form
12.2.6.3. Market Revenue and Volume Forecast, by Application/Functionality
12.2.6.4. Market Revenue and Volume Forecast, by End-User
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product Type
12.2.7.2. Market Revenue and Volume Forecast, by Form
12.2.7.3. Market Revenue and Volume Forecast, by Application/Functionality
12.2.7.4. Market Revenue and Volume Forecast, by End-User
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product Type
12.2.8.2. Market Revenue and Volume Forecast, by Form
12.2.8.3. Market Revenue and Volume Forecast, by Application/Functionality
12.2.8.4. Market Revenue and Volume Forecast, by End-User
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product Type
12.3.2. Market Revenue and Volume Forecast, by Form
12.3.3. Market Revenue and Volume Forecast, by Application/Functionality
12.3.4. Market Revenue and Volume Forecast, by End-User
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product Type
12.3.5.2. Market Revenue and Volume Forecast, by Form
12.3.5.3. Market Revenue and Volume Forecast, by Application/Functionality
12.3.5.4. Market Revenue and Volume Forecast, by End-User
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product Type
12.3.6.2. Market Revenue and Volume Forecast, by Form
12.3.6.3. Market Revenue and Volume Forecast, by Application/Functionality
12.3.6.4. Market Revenue and Volume Forecast, by End-User
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product Type
12.3.7.2. Market Revenue and Volume Forecast, by Form
12.3.7.3. Market Revenue and Volume Forecast, by Application/Functionality
12.3.7.4. Market Revenue and Volume Forecast, by End-User
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product Type
12.3.8.2. Market Revenue and Volume Forecast, by Form
12.3.8.3. Market Revenue and Volume Forecast, by Application/Functionality
12.3.8.4. Market Revenue and Volume Forecast, by End-User
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product Type
12.4.2. Market Revenue and Volume Forecast, by Form
12.4.3. Market Revenue and Volume Forecast, by Application/Functionality
12.4.4. Market Revenue and Volume Forecast, by End-User
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product Type
12.4.5.2. Market Revenue and Volume Forecast, by Form
12.4.5.3. Market Revenue and Volume Forecast, by Application/Functionality
12.4.5.4. Market Revenue and Volume Forecast, by End-User
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product Type
12.4.6.2. Market Revenue and Volume Forecast, by Form
12.4.6.3. Market Revenue and Volume Forecast, by Application/Functionality
12.4.6.4. Market Revenue and Volume Forecast, by End-User
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product Type
12.4.7.2. Market Revenue and Volume Forecast, by Form
12.4.7.3. Market Revenue and Volume Forecast, by Application/Functionality
12.4.7.4. Market Revenue and Volume Forecast, by End-User
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product Type
12.4.8.2. Market Revenue and Volume Forecast, by Form
12.4.8.3. Market Revenue and Volume Forecast, by Application/Functionality
12.4.8.4. Market Revenue and Volume Forecast, by End-User
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product Type
12.5.2. Market Revenue and Volume Forecast, by Form
12.5.3. Market Revenue and Volume Forecast, by Application/Functionality
12.5.4. Market Revenue and Volume Forecast, by End-User
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product Type
12.5.5.2. Market Revenue and Volume Forecast, by Form
12.5.5.3. Market Revenue and Volume Forecast, by Application/Functionality
12.5.5.4. Market Revenue and Volume Forecast, by End-User
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product Type
12.5.6.2. Market Revenue and Volume Forecast, by Form
12.5.6.3. Market Revenue and Volume Forecast, by Application/Functionality
12.5.6.4. Market Revenue and Volume Forecast, by End-User
13.1. Roquette Freres
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial PerProduct Typeance
13.1.4. Recent Initiatives
13.2. DFE Pharma
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial PerProduct Typeance
13.2.4. Recent Initiatives
13.3. Ashland Global Holdings Inc
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial PerProduct Typeance
13.3.4. Recent Initiatives
13.4. BASF SE
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial PerProduct Typeance
13.4.4. Recent Initiatives
13.5. Cargill, Incorporated
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial PerProduct Typeance
13.5.4. Recent Initiatives
13.6. Archer Daniels Midland Company (ADM)
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial PerProduct Typeance
13.6.4. Recent Initiatives
13.7. Associated British Foods (SPI Pharma)
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial PerProduct Typeance
13.7.4. Recent Initiatives
13.8. Ingredion Incorporated
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial PerProduct Typeance
13.8.4. Recent Initiatives
13.9. JRS Pharma GmbH & Co. KG
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial PerProduct Typeance
13.9.4. Recent Initiatives
13.10. Colorcon, Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial PerProduct Typeance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client